These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 6724695)

  • 1. Principles underlying rational design of live attenuated influenza vaccines.
    Jang YH; Seong BL
    Clin Exp Vaccine Res; 2012 Jul; 1(1):35-49. PubMed ID: 23596576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
    Marcelin G; Sandbulte MR; Webby RJ
    Rev Med Virol; 2012 Jul; 22(4):267-79. PubMed ID: 22438243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
    Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
    PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination.
    Chirkova T; Petukhova G; Korenkov D; Naikhin A; Rudenko L
    Influenza Other Respir Viruses; 2008 Sep; 2(5):165-74. PubMed ID: 19453421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees.
    Alexandrova GI; Polezhaev FI; Budilovsky GN; Garmashova LM; Topuria NA; Egorov AY; Romejko-Gurko YR; Koval TA; Lisovskaya KV; Klimov AI
    Infect Immun; 1984 Jun; 44(3):734-9. PubMed ID: 6724695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
    Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
    Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
    Ghendon YZ; Polezhaev FI; Lisovskaya KV; Medvedeva TE; Alexandrova GI; Klimov AI
    Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
    Garmashova LM; Polezhaev FI; Aleksandrova GI
    Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the structure of the populations of inhibitor-sensitive and inhibitor-resistant A2 influenza virus strains.
    ALEXANDROVA GI
    Acta Virol; 1962 Nov; 6():487-97. PubMed ID: 14040990
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.